890PEverolimus as first-line or after cytokine therapy in patients with metastatic recurrent and/or unresectable renal cell carcinoma (RCC) (EVERMORE).

Autor:	Hakim, A M Abdel1 (AUTHOR), Nouira, Y2 (AUTHOR), Taran, R3 (AUTHOR), Amokrane, D4 (AUTHOR), Ghosn, M5 (AUTHOR), Larbaoui, B6 (AUTHOR), Pripatnanont, C7 (AUTHOR), Slimane, K8 (AUTHOR), Pilipovic, V9 (AUTHOR), Boussen, H10 (AUTHOR)
Zdroj:	Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu